Arcus Biosciences, Inc. (RCUS) Social Stream
ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ARCUS BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $70 | $50 | $59.833 | $17.62 | 239.57% |
| 2021-11-17 | 8 | $70 | $48 | $58.142 | $17.62 | 229.98% |
| 2021-11-18 | 8 | $100 | $48 | $62.714 | $17.62 | 255.93% |
| 2021-11-22 | 9 | $100 | $50 | $64.875 | $17.62 | 268.19% |
| 2022-02-24 | 7 | $100.001 | $53 | $67 | $17.62 | 280.25% |
| 2022-04-12 | 7 | $100.001 | $53 | $68 | $17.62 | 285.93% |
| 2022-05-10 | 7 | $77 | $53 | $63.143 | $17.62 | 258.36% |
| 2022-05-13 | 7 | $77 | $42 | $59.571 | $17.62 | 238.09% |
| 2022-07-08 | 7 | $66 | $42 | $55.714 | $17.62 | 216.2% |
| 2022-08-04 | 7 | $60 | $36 | $50.428 | $17.62 | 186.2% |
| 2022-08-18 | 7 | $60 | $36 | $48.571 | $17.62 | 175.66% |
| 2022-08-31 | 7 | $60 | $36 | $49 | $17.62 | 178.09% |
| 2022-10-11 | 9 | $60 | $36 | $47.875 | $17.62 | 171.71% |
| 2022-10-14 | 8 | $60 | $36 | $45.285 | $17.62 | 157.01% |
| 2022-11-03 | 8 | $60 | $36 | $45.125 | $17.62 | 156.1% |
| 2022-11-18 | 7 | $51 | $33 | $41.75 | $17.62 | 136.95% |
| 2022-11-23 | 8 | $51 | $33 | $41.375 | $17.62 | 134.82% |
| 2022-12-20 | 9 | $51 | $24 | $40.875 | $17.62 | 131.98% |
| 2022-12-22 | 9 | $51 | $36 | $42.375 | $17.62 | 140.49% |
| 2023-01-09 | 9 | $51 | $36 | $42.375 | $17.62 | 140.49% |
| 2023-03-01 | 9 | $51 | $24 | $40.875 | $17.62 | 131.98% |
| 2023-03-02 | 9 | $51 | $23 | $40.75 | $17.62 | 131.27% |
| 2023-03-09 | 9 | $51 | $23 | $40.5 | $17.62 | 129.85% |
The Trend in the Analyst Price Target
RCUS's average price target has moved up $2.5 over the prior 33 months.
RCUS reports an average of 107% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-30 | 7 | 100.001 | 53 | 68.000 | 33.40 | 103.59% |
| 2022-04-01 | 7 | 100.001 | 53 | 68.000 | 31.99 | 112.57% |
| 2022-04-12 | 7 | 100.001 | 53 | 68.000 | 30.75 | 121.14% |
| 2022-11-03 | 8 | 60.000 | 36 | 45.125 | 24.37 | 85.17% |
| 2023-03-09 | 9 | 51.000 | 23 | 40.500 | 16.58 | 144.27% |
RCUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 90 days, RCUS's average broker recommendation rating improved by 0.11.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCUS as an investment opportunity.
- In terms of how ARCUS BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2639.68% of that group.
- RCUS has a lower variance in analysts' estimates than -1861.94% of all US stocks.
- RCUS has a greater average analyst price target than 2257.45% of Pharmaceutical Products stocks.
- RCUS has a greater number of analysts covering the stock than 1933.06% of Pharmaceutical Products stocks.
Stocks similar to ARCUS BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APLS, DCPH, and ZYME.
View All Top Stocks by Price Target
Make investment decisions regarding RCUS using the data that counts. Try POWR Ratings for free.